Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01117636Phase 3Completed
Phase 3, randomised, double-blind trial of aspirin in odontalgia (3 arms), sponsored by Bayer. Primary endpoints: Time to First Perceptible Pain Relief (PR) and Time to First Perceptible Pain Relief (PR) Confirmed. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01117636.